Frequency of interatrial block in patients with sinus rhythm hospitalized for stroke and comparison to those without

Vignendra Ariyarajah1, Sirin Apiyasawat, Husam Najjar

  • 1Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Veterans Affairs Boston Healthcare System, Boston, MA, USA. vignendra@hotmail.com

Insights

Interatrial block (IAB) is linked to enlarged left atria and increased risk of embolic stroke. Further research is needed to explore anticoagulation for patients with IAB and stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Electrophysiology

Background:

  • Interatrial block (IAB) correlates with left atrial enlargement and dysfunction.
  • IAB predicts atrial tachyarrhythmias, increasing embolism risk.
  • The link between IAB and cardioembolic stroke requires further investigation.

Purpose of the Study:

  • To investigate the association between Interatrial block (IAB) and embolic stroke.
  • To evaluate left atrial (LA) abnormalities in stroke patients with and without IAB.

Main Methods:

  • Retrospective analysis of 85 patients admitted for embolic stroke.
  • ECG evaluation for IAB in 66 patients in sinus rhythm.
  • Review of medical records, carotid Doppler, and echocardiograms for LA enlargement, thrombi, and spontaneous contrast.

Main Results:

  • 61% of embolic stroke patients exhibited IAB.
  • 55% prevalence of left atrial enlargement in patients with IAB.
  • LA thrombi or spontaneous contrast observed in 15% of IAB patients, none in controls.

Conclusions:

  • IAB may be a risk factor for embolic stroke due to associated LA dilation and dysfunction.
  • IAB-related thrombosis could predispose patients to stroke.
  • Prospective studies are warranted to confirm this association and evaluate anticoagulation strategies.

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.